NeuroBytes: Anticoagulation Reversal in Intracerebral Hemorrhage
Course Description
Learning Objectives
- Describe the mechanism of common anticoagulation medications and the mechanism, indications, and dosing for their respective reversal agents.
Date of Release
Confidentiality of Data
Faculty & Disclosures
Neurocritical Care Fellow
Johns Hopkins Hospital
Baltimore, MD
*Dr. Bower has nothing to disclose.
Editor
SARA STERN-NEZER, MD
Associate Clinical Professor, Neurology
University of California School of Medicine
Irvine, CA
*Dr. Stern-Nezer has nothing to disclose.
Reviewer
CALLI LEIGHANN COOK, DNP, FNP-C
Clinical Assistant Professor, Emory Nell Hodgson
Woodruff School of Nursing
Nurse Practitioner, Emory Brain Health Center
Atlanta, GA
*Dr. Cook has nothing to disclose.
Voiceover Artist
Tessa Dahlgren
eLearning Production Program Manager
American Academy of Neurology
Minneapolis, MN
*Ms. Dahlgren has nothing to disclose.
NeuroBytes Staff
Xiaoyu Sun, Associate Director, eLearning
Minneapolis, MN
*Ms. Sun has nothing to disclose.
Zach Cramer, Program Manager, eLearning
Minneapolis, MN
*Mr. Cramer has nothing to disclose.
Sulia Altenberg, eLearning Coordinator
Minneapolis, MN
*Ms. Altenberg has nothing to disclose.
*Relationship Disclosure